CDIO 株価推移チャート
CDIO 財務
Cardio Diagnostics Holdings Inc
$1.55
-7.73%
$-0.12
終値： May 15, 16:00:00 GMT-4
$1.57
1.29%
$0.02
アフターマーケット：May 15, 20:00:00 GMT-4
戻る
Cardio Diagnostics Holdings Inc (CDIO) 財務
主要データ
前終値
$1.68
始値
$1.7
当日レンジ
$1.5 - $1.7
52週レンジ
$0.97 - $7.91
取引高
64.9K
平均取引高
2.7M
配当利回り
--
1株当たり利益(TTM)
-3.72
時価総額
$4.6M
CDIOとは何ですか？
Cardio Diagnostics Holdings, Inc. engages in the provision of medical diagnostic testing services. The company is headquartered in Chicago, Illinois and currently employs 15 full-time employees. The company went IPO on 2021-11-23. The firm develops and commercializes a series of products for various types of cardiovascular disease and associated co-morbidities, including coronary heart disease (CHD), stroke, heart failure and diabetes, by leveraging its artificial intelligence (AI)-driven Integrated Genetic-Epigenetic Engine. Its first product, Epi+Gen CHD, is an epigenetics-based clinical blood test capable of assessing near-term (three-year) risk for CHD, and its second product, PrecisionCHD, is an epigenetics-based clinical blood test for the detection of CHD. CardioInnovate360 is a research use only (RUO) solution to support the discovery, development, and validation of biopharmaceuticals for the assessment and management of cardiovascular diseases. HeartRisk is a cardiovascular risk intelligence platform that combines insights from anonymized and aggregated clinical cardiovascular data.
